|
⚲
|
| Keyboard |
| Atillasoy Ercem
✚
|
|
|---|---|
| CIK # | 0001818802 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818802] | |
| 4 | [0001818802] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Atillasoy Ercem | |
| Kalaris Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-10-20 | Sell | 1,527 | $8.48 | 12,949 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-10-19 | Sell | 568 | $9.36 | 5,316 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-07-21 | Sell | 1,533 | $5.38 | 8,248 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-07-20 | Sell | 563 | $5.21 | 2,933 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-07-01 | Grant | 14,000 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Stock Option (Right to Buy) · derivative
|
2022-07-01 | Grant | 26,000 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-04-21 | Sell | 1,587 | $5.86 | 9,300 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-04-20 | Sell | 453 | $6.68 | 3,026 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-01-25 | Sell | 4,639 | $8.24 | 38,225 |
|
Kalaris Therapeutics Inc ALVR
Stock Option (Right to Buy) · derivative
|
2022-01-18 | Grant | 56,744 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2022-01-18 | Grant | 23,256 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2021-10-21 | Sell | 1,514 | $24.23 | 36,684 |
|
Kalaris Therapeutics Inc ALVR
Stock Option (Right to Buy) · derivative
|
2021-01-19 | Grant | 52,000 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2021-01-19 | Grant | 28,000 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2020-08-03 | Buy | 3,500 | $17.00 | 59,500 |
|
Kalaris Therapeutics Inc ALVR
Common Stock
|
2020-07-29 | Grant | 75,000 | $0.00 | |
|
Kalaris Therapeutics Inc ALVR
Stock Option (Right to Buy) · derivative
|
2020-07-29 | Grant | 407,400 | $0.00 |